DK2081950T3 - Med irinotecanbehandling forbundne ekspressionsprofiler - Google Patents
Med irinotecanbehandling forbundne ekspressionsprofilerInfo
- Publication number
- DK2081950T3 DK2081950T3 DK07867158.3T DK07867158T DK2081950T3 DK 2081950 T3 DK2081950 T3 DK 2081950T3 DK 07867158 T DK07867158 T DK 07867158T DK 2081950 T3 DK2081950 T3 DK 2081950T3
- Authority
- DK
- Denmark
- Prior art keywords
- expression profiles
- profiles associated
- irinotecan treatment
- irinotecan
- treatment
- Prior art date
Links
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 title 1
- 229960004768 irinotecan Drugs 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84629806P | 2006-09-21 | 2006-09-21 | |
| US90643807P | 2007-03-12 | 2007-03-12 | |
| PCT/US2007/020498 WO2008073177A2 (en) | 2006-09-21 | 2007-09-21 | Expression profiles associated with irinotecan treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2081950T3 true DK2081950T3 (da) | 2013-06-03 |
Family
ID=39512250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07867158.3T DK2081950T3 (da) | 2006-09-21 | 2007-09-21 | Med irinotecanbehandling forbundne ekspressionsprofiler |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20080076134A1 (da) |
| EP (1) | EP2081950B1 (da) |
| DK (1) | DK2081950T3 (da) |
| ES (1) | ES2405654T3 (da) |
| WO (1) | WO2008073177A2 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110059464A1 (en) * | 2008-04-08 | 2011-03-10 | Muraca Patrick J | Biomarker Panel For Prediction Of Recurrent Colorectal Cancer |
| WO2010062705A1 (en) * | 2008-11-03 | 2010-06-03 | Quest Diagnostics Investments Incorporated | Cancer diagnosis using ki-67 |
| CN102325905B (zh) * | 2009-03-13 | 2014-07-16 | 株式会社益力多本社 | 伊立替康的敏感性判断方法及其利用 |
| DK177532B1 (en) | 2009-09-17 | 2013-09-08 | Bio Bedst Aps | Medical use of sPLA2 hydrolysable liposomes |
| US9459254B2 (en) * | 2009-10-30 | 2016-10-04 | Keio University | Method for determining sensitivity to an anticancer agent |
| JP5548694B2 (ja) * | 2009-10-30 | 2014-07-16 | 学校法人慶應義塾 | 抗がん剤の感受性の判定方法 |
| EP2589665A4 (en) * | 2010-06-29 | 2013-11-20 | Univ Kurume | METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF IMMUNOTHERAPY ON A CANCER PATIENTS AND THE METHOD AND KIT USED IN THE METHOD |
| US20140273273A1 (en) * | 2012-11-01 | 2014-09-18 | Christie Mitchell Ballantyne | Biomarkers to improve prediction of heart failure risk |
| EP2881472A1 (en) | 2013-12-09 | 2015-06-10 | Université Pierre et Marie Curie (Paris 6) | A method of predicting a response to an anti-tumor treatment |
| US10570457B2 (en) | 2014-09-26 | 2020-02-25 | Medical Prognosis Institute A/S | Methods for predicting drug responsiveness |
| EP3302060B1 (en) * | 2015-05-26 | 2020-02-12 | Kaohsiung Medical University | Pyrazolo[4,3-c]quinoline derivatives for inhibition of -glucuronidase |
| US9725769B1 (en) | 2016-10-07 | 2017-08-08 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
| AU2017258901A1 (en) | 2016-12-30 | 2018-07-19 | Allarity Therapeutics Europe ApS | Methods for predicting drug responsiveness in cancer patients |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6350894A (en) * | 1993-03-05 | 1994-09-26 | Clifford W. Schweinfest | Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas |
| US6455251B1 (en) * | 1994-09-13 | 2002-09-24 | Thomas Jefferson University | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| EP0847398A4 (en) * | 1995-06-06 | 2003-02-05 | Human Genome Sciences Inc | COLON-SPECIFIC GENES AND PROTEINS |
| US6337195B1 (en) * | 1995-06-06 | 2002-01-08 | Human Genome Sciences, Inc. | Colon specific genes and proteins |
| US6602659B1 (en) * | 1996-05-03 | 2003-08-05 | Thomas Jefferson University | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| WO1999033963A1 (en) * | 1997-12-31 | 1999-07-08 | Chiron Corporation | Metastatic cancer regulated gene |
| US6949339B1 (en) * | 1998-05-21 | 2005-09-27 | Diadexus, Inc. | Method of diagnosing, monitoring, and staging colon cancer |
| ATE386804T1 (de) * | 1998-10-15 | 2008-03-15 | Novartis Vaccines & Diagnostic | Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen |
| US6773878B1 (en) * | 1999-11-09 | 2004-08-10 | Eos Biotechnology, Inc. | Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| EP1167045A4 (en) * | 1999-03-31 | 2007-07-11 | Canon Finetech Inc | PRINTER |
| US6455668B1 (en) * | 2000-01-28 | 2002-09-24 | Eos Biotechnology, Inc. | Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| US6566502B1 (en) * | 2000-01-28 | 2003-05-20 | Eos Biotechnology, Inc. | Methods of diagnosing cancer, compositions, and methods of screening for cancer modulators |
| US6682890B2 (en) * | 2000-08-17 | 2004-01-27 | Protein Design Labs, Inc. | Methods of diagnosing and determining prognosis of colorectal cancer |
| US6794501B2 (en) * | 2001-05-04 | 2004-09-21 | Ludwig Institute For Cancer Research | Colon cancer antigen panel |
| EP1340818A1 (en) * | 2002-02-27 | 2003-09-03 | Epigenomics AG | Method and nucleic acids for the analysis of a colon cell proliferative disorder |
| DK1918386T3 (da) * | 2002-03-13 | 2012-01-02 | Genomic Health Inc | Genekspressionsprofiler i biopsier af tumorvæv |
| AU2003235470A1 (en) * | 2002-06-19 | 2004-01-06 | Smithkline Beecham Corporation | Predictive markers in cancer therapy |
| US20040203034A1 (en) * | 2003-01-03 | 2004-10-14 | The University Of Chicago | Optimization of cancer treatment with irinotecan |
| WO2004066941A2 (en) * | 2003-01-24 | 2004-08-12 | Bayer Pharmaceuticals Corporation | Expression profiles for colon cancer and methods of use |
| CA2515096A1 (en) * | 2003-02-06 | 2004-08-26 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| US20080014579A1 (en) * | 2003-02-11 | 2008-01-17 | Affymetrix, Inc. | Gene expression profiling in colon cancers |
| ES2690168T3 (es) * | 2003-06-24 | 2018-11-19 | Genomic Health, Inc. | Predicción de la probabilidad de recidiva de cáncer |
| US20050009110A1 (en) * | 2003-07-08 | 2005-01-13 | Xiao-Jia Chang | Methods of producing antibodies for diagnostics and therapeutics |
| US20050227266A1 (en) * | 2004-02-06 | 2005-10-13 | Ross Douglas T | Biomarker:compound correlations in cancer diagnosis and therapy |
| ES2636470T3 (es) * | 2004-04-09 | 2017-10-05 | Genomic Health, Inc. | Marcadores de expresión génica para predecir la respuesta a la quimioterapia |
| US7794960B2 (en) * | 2004-06-04 | 2010-09-14 | Glaxosmithkline Llc | Predictive biomarkers in cancer therapy |
| CA2585571C (en) * | 2004-11-05 | 2020-01-21 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
| ATE550440T1 (de) * | 2004-11-05 | 2012-04-15 | Genomic Health Inc | Molekulare indikatoren für brustkrebsprognose und vorhersage des ansprechens auf eine behandlung |
| US8383357B2 (en) * | 2005-03-16 | 2013-02-26 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| US8329408B2 (en) * | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
| US20070221273A1 (en) * | 2006-03-22 | 2007-09-27 | Landers Jerry L | Valve for beverage dispenser |
-
2007
- 2007-09-21 WO PCT/US2007/020498 patent/WO2008073177A2/en not_active Ceased
- 2007-09-21 EP EP07867158A patent/EP2081950B1/en not_active Not-in-force
- 2007-09-21 ES ES07867158T patent/ES2405654T3/es active Active
- 2007-09-21 DK DK07867158.3T patent/DK2081950T3/da active
- 2007-09-21 US US11/903,470 patent/US20080076134A1/en not_active Abandoned
-
2008
- 2008-09-22 US US12/284,387 patent/US7763438B2/en not_active Expired - Fee Related
-
2009
- 2009-06-18 US US12/487,061 patent/US8580926B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8580926B2 (en) | 2013-11-12 |
| ES2405654T3 (es) | 2013-05-31 |
| US20090047684A1 (en) | 2009-02-19 |
| WO2008073177A2 (en) | 2008-06-19 |
| US7763438B2 (en) | 2010-07-27 |
| EP2081950B1 (en) | 2013-03-20 |
| US20090298084A1 (en) | 2009-12-03 |
| WO2008073177A3 (en) | 2008-11-06 |
| EP2081950A4 (en) | 2010-03-17 |
| EP2081950A2 (en) | 2009-07-29 |
| US20080076134A1 (en) | 2008-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2081950T3 (da) | Med irinotecanbehandling forbundne ekspressionsprofiler | |
| DK2215110T3 (da) | Alfa-amylasevarianter med ændrede egenskaber | |
| BRPI0910854A2 (pt) | métodos de tratamento | |
| BRPI0910259A2 (pt) | métodos de tratamento de inflamação | |
| DK2106215T3 (da) | Brød med forhøjet arabinoxylo-oligosaccharid-indhold | |
| DK2245130T3 (da) | Ts23 -alpha-amylasevarianter med ændrede egenskaber | |
| DK2479265T3 (da) | Glucoamylasevarianter med ændrede egenskaber | |
| DK2099453T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
| DK2035369T3 (da) | Terapeutiske | |
| DE502008000740D1 (de) | Rollosystem | |
| DK2173831T3 (da) | Brøndbehandling | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| HRP20160577T1 (hr) | Liječenje osteoartritisa | |
| DK1927646T3 (da) | Odoriseringsmiddel med forbedret stabilitet | |
| DK2246477T3 (da) | Spunspæl med dobbelt t-form | |
| PT3133396T (pt) | Métodos de tratamento utilizando fármacos eliminadores de amoníaco | |
| AT506770A3 (de) | Walze | |
| DK2054412T3 (da) | Imino-imidazo-pyridinderivater med antitrombotisk virkning | |
| DE102006028487B8 (de) | Rollladenpanzer | |
| FI20060555L (fi) | Saunankiuas | |
| ITMI20060187U1 (it) | Catetere orientabile | |
| ES1065966Y (es) | Ladrillo perfeccionado | |
| FIU20070195U0 (fi) | Kaasunkäsittelylaitteisto | |
| FI7219U1 (fi) | Hoitopöytä | |
| UA14838S (uk) | Ванна гідромасажна |